Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of Nerve Blocks for Shoulder-Hand Syndrome
NCT03291197Phase 4Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Oct 2017
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine, triamcinolone acetonide in complex regional pain syndrome type I (CRPS), sponsored by Ottawa Hospital Research Institute. Started Oct 2017; status: completed.
02
Drugs
bupivacainetriamcinolone acetonide
03
Conditions
complex regional pain syndrome type I (CRPS)
Beyond the preview
Go deeper on NCT03291197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291197.